Funded Startups in Macclesfield
In Macclesfield, the disclosed deal sizes show a clear outlier: Gelmetix raised $7M (2021-05-14), while the next-largest disclosed amount is Acquired.com’s…
In Macclesfield, the disclosed deal sizes show a clear outlier: Gelmetix raised $7M (2021-05-14), while the next-largest disclosed amount is Acquired.com’s $5M (2024-10-14); all other disclosed figures fall to $1M (Alderley Lighthouse Labs, 2023-08-14), $700K (Cryoniss, 2022-01-17). Sector-wise, Health and Human Services ($1M on 2023-08-14), Biotechnology ($7M on 2021-05-14), and Financial Services ($5M on 2024-10-14) all appear, but Financial Services is represented by just one disclosed round versus a single each in the other named sectors.
Temporally, the five most recent rows span 2021-05-14 through 2025-11-19, clustering more recent activity in 2024–2025: Acquired.com (2024-10-14, $5M) and Zuto (2025-11-19, undisclosed) sit just after an earlier $1M event in 2023 and a mid-window $700K round in 2022. On stage labels, five of the five entries are “Series Unknown” or blank, with only Cryoniss explicitly tagged as Seed (2022-01-17).
Most recent rounds
5 shownRelated listings
Frequently asked
What’s the largest disclosed round in Macclesfield here, and how does it compare to the rest of the disclosed amounts?
Gelmetix’s $7M (2021-05-14) is the largest disclosed amount, only modestly above Acquired.com’s $5M (2024-10-14); the remaining disclosed rounds are much smaller at $1M (Alderley Lighthouse Labs, 2023-08-14) and $700K (Cryoniss, 2022-01-17).
Do the most recent rounds cluster into a narrow time window, or are they evenly spread across years?
They cluster toward the recent end: two entries fall in 2024–2025 (Acquired.com on 2024-10-14 and Zuto on 2025-11-19), with the next disclosed rounds stepping back to 2023-08-14 ($1M) and 2022-01-17 ($700K). The earliest disclosed amount shown is Gelmetix’s 2021-05-14 $7M.
Are any sectors over-represented in this small set, or is it evenly distributed?
In these five rows, sectors are not concentrated: Financial Services appears once with a disclosed amount ($5M on 2024-10-14 by Acquired.com), Biotechnology appears once ($7M on 2021-05-14 by Gelmetix), and Health and Human Services appears once ($1M on 2023-08-14 by Alderley Lighthouse Labs), with the remaining two entries in Other (Cryoniss) and a blank sector label pattern not shown as another repeat.
How dominant is the stage labeling, and are there meaningful outliers in stage classification?
Stage detail is limited: four entries are “Series Unknown” (Zuto 2025-11-19 undisclosed; Acquired.com 2024-10-14 $5M; Alderley Lighthouse Labs 2023-08-14 $1M; Zuto and the other are “Series Unknown”), one entry has a blank stage label (Gelmetix on 2021-05-14 $7M), and only Cryoniss is explicitly tagged as Seed (2022-01-17 $700K).
Is there a notable outlier due to undisclosed funding versus disclosed amounts?
Yes: Zuto (2025-11-19) is listed with an undisclosed amount, while the other disclosed rounds range from $700K to $7M (Cryoniss at $700K in 2022-01-17 and Gelmetix at $7M in 2021-05-14). This makes the only fully comparable size profile rely on the four disclosed entries.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.